Robert Burns
Stock Analyst at HC Wainwright & Co.
(3.03)
# 1,440
Out of 5,090 analysts
477
Total ratings
40.14%
Success rate
1.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NUVB Nuvation Bio | Reiterates: Buy | $10 | $8.31 | +20.34% | 16 | Dec 1, 2025 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $24 → $26 | $10.59 | +145.51% | 3 | Nov 20, 2025 | |
| ZYME Zymeworks | Maintains: Buy | $26 → $32 | $26.43 | +21.07% | 23 | Nov 18, 2025 | |
| ORIC ORIC Pharmaceuticals | Maintains: Buy | $19 → $23 | $11.41 | +101.58% | 26 | Nov 14, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $21 → $50 | $39.36 | +27.03% | 15 | Nov 13, 2025 | |
| BNTX BioNTech SE | Maintains: Buy | $136 → $140 | $95.99 | +45.85% | 46 | Nov 10, 2025 | |
| ACET Adicet Bio | Maintains: Buy | $4 → $9 | $0.56 | +1,493.77% | 2 | Nov 7, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $72 → $73 | $78.51 | -7.01% | 21 | Nov 6, 2025 | |
| EXEL Exelixis | Maintains: Buy | $46 → $49 | $44.40 | +10.37% | 11 | Nov 5, 2025 | |
| CRBU Caribou Biosciences | Maintains: Buy | $3 → $9 | $1.94 | +365.12% | 15 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $2 | $1.38 | +44.93% | 22 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.11 | +352.49% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3 | $2.24 | +34.23% | 19 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $28 | $18.00 | +55.56% | 19 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $10.50 | +14.34% | 20 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $7 | $5.15 | +35.92% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $3.54 | +97.74% | 22 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 | $5.89 | +154.67% | 3 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.39 | +318.41% | 5 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.54 | +224.68% | 17 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $11.45 | +135.91% | 1 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $4.88 | +63.93% | 9 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $20 | $9.74 | +105.34% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $2.64 | +1,187.88% | 4 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $8.00 | +75.11% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $18.86 | +112.15% | 5 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $42 | $24.21 | +73.48% | 11 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $2.71 | +269.17% | 14 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $10 | $2.16 | +362.96% | 3 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $8.34 | +55.97% | 8 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $21.55 | +122.79% | 5 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.00 | +501.50% | 3 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $9.88 | +31.58% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.29 | +287.60% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $1.45 | +453.63% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $14.19 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $14.75 | +1,256.39% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,320 → $240 | $1.54 | +15,484.42% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.63 | +23,800.57% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $4.09 | +168.95% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50,000 → $45,000 | $4.42 | +1,016,895.12% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $4.52 | +453.71% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.57 | +728.03% | 1 | Jan 7, 2021 |
Nuvation Bio
Dec 1, 2025
Reiterates: Buy
Price Target: $10
Current: $8.31
Upside: +20.34%
Cullinan Therapeutics
Nov 20, 2025
Maintains: Buy
Price Target: $24 → $26
Current: $10.59
Upside: +145.51%
Zymeworks
Nov 18, 2025
Maintains: Buy
Price Target: $26 → $32
Current: $26.43
Upside: +21.07%
ORIC Pharmaceuticals
Nov 14, 2025
Maintains: Buy
Price Target: $19 → $23
Current: $11.41
Upside: +101.58%
Cogent Biosciences
Nov 13, 2025
Maintains: Buy
Price Target: $21 → $50
Current: $39.36
Upside: +27.03%
BioNTech SE
Nov 10, 2025
Maintains: Buy
Price Target: $136 → $140
Current: $95.99
Upside: +45.85%
Adicet Bio
Nov 7, 2025
Maintains: Buy
Price Target: $4 → $9
Current: $0.56
Upside: +1,493.77%
Revolution Medicines
Nov 6, 2025
Maintains: Buy
Price Target: $72 → $73
Current: $78.51
Upside: -7.01%
Exelixis
Nov 5, 2025
Maintains: Buy
Price Target: $46 → $49
Current: $44.40
Upside: +10.37%
Caribou Biosciences
Nov 5, 2025
Maintains: Buy
Price Target: $3 → $9
Current: $1.94
Upside: +365.12%
Nov 3, 2025
Reiterates: Neutral
Price Target: $2
Current: $1.38
Upside: +44.93%
Oct 31, 2025
Upgrades: Buy
Price Target: $5
Current: $1.11
Upside: +352.49%
Oct 27, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $2.24
Upside: +34.23%
Oct 27, 2025
Maintains: Buy
Price Target: $33 → $28
Current: $18.00
Upside: +55.56%
Oct 27, 2025
Upgrades: Buy
Price Target: $12
Current: $10.50
Upside: +14.34%
Oct 20, 2025
Assumes: Buy
Price Target: $7
Current: $5.15
Upside: +35.92%
Oct 16, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.54
Upside: +97.74%
Oct 13, 2025
Upgrades: Buy
Price Target: $15
Current: $5.89
Upside: +154.67%
Oct 3, 2025
Reiterates: Buy
Price Target: $10
Current: $2.39
Upside: +318.41%
Sep 23, 2025
Reiterates: Buy
Price Target: $5
Current: $1.54
Upside: +224.68%
Sep 15, 2025
Initiates: Buy
Price Target: $27
Current: $11.45
Upside: +135.91%
Sep 12, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $4.88
Upside: +63.93%
Sep 10, 2025
Maintains: Buy
Price Target: $23 → $20
Current: $9.74
Upside: +105.34%
Aug 26, 2025
Reiterates: Buy
Price Target: $34
Current: $2.64
Upside: +1,187.88%
Aug 26, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $8.00
Upside: +75.11%
Aug 22, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $18.86
Upside: +112.15%
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $24.21
Upside: +73.48%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.71
Upside: +269.17%
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $2.16
Upside: +362.96%
Jul 17, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $8.34
Upside: +55.97%
Jul 2, 2025
Maintains: Buy
Price Target: $40 → $48
Current: $21.55
Upside: +122.79%
May 16, 2025
Reiterates: Buy
Price Target: $12
Current: $2.00
Upside: +501.50%
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $9.88
Upside: +31.58%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.29
Upside: +287.60%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.45
Upside: +453.63%
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $14.19
Upside: -
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $14.75
Upside: +1,256.39%
Mar 21, 2024
Maintains: Buy
Price Target: $1,320 → $240
Current: $1.54
Upside: +15,484.42%
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $0.63
Upside: +23,800.57%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $4.09
Upside: +168.95%
Nov 24, 2021
Maintains: Buy
Price Target: $50,000 → $45,000
Current: $4.42
Upside: +1,016,895.12%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $4.52
Upside: +453.71%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.57
Upside: +728.03%